Çağlar Çağlayan1, Hiromi Terawaki1, Qiushi Chen1, Ashish Rai1, Turgay Ayer1, Christopher R Flowers1. 1. Çağlar Çağlayan and Turgay Ayer, Georgia Institute of Technology; Hiromi Terawaki and Christopher R. Flowers, Emory University; Ashish Rai, American Cancer Society, Atlanta GA; and Qiushi Chen, Massachusetts General Hospital, Boston MA.
Abstract
PURPOSE: Microsimulation is a modeling technique that uses a sample size of individual units (microunits), each with a unique set of attributes, and allows for the simulation of downstream events on the basis of predefined states and transition probabilities between those states over time. In this article, we describe the history of the role of microsimulation in medicine and its potential applications in oncology as useful tools for population risk stratification and treatment strategy design for precision medicine. METHODS: We conducted a comprehensive and methodical search of the literature using electronic databases-Medline, Embase, and Cochrane-for works published between 1985 and 2016. A medical subject heading search strategy was constructed for Medline searches by using a combination of relevant search terms, such as "microsimulation model medicine," "multistate modeling cancer," and "oncology." RESULTS: Microsimulation modeling is particularly useful for the study of optimal intervention strategies when randomized control trials may not be feasible, ethical, or practical. Microsimulation models can retain memory of prior behaviors and states. As such, it allows an explicit representation and understanding of how various processes propagate over time and affect the final outcomes for an individual or in a population. CONCLUSION: A well-calibrated microsimulation model can be used to predict the outcome of the event of interest for a new individual or subpopulations, assess the effectiveness and cost effectiveness of alternative interventions, and project the future disease burden of oncologic diseases. In the growing field of oncology research, a microsimulation model can serve as a valuable tool among the various facets of methodology available.
PURPOSE: Microsimulation is a modeling technique that uses a sample size of individual units (microunits), each with a unique set of attributes, and allows for the simulation of downstream events on the basis of predefined states and transition probabilities between those states over time. In this article, we describe the history of the role of microsimulation in medicine and its potential applications in oncology as useful tools for population risk stratification and treatment strategy design for precision medicine. METHODS: We conducted a comprehensive and methodical search of the literature using electronic databases-Medline, Embase, and Cochrane-for works published between 1985 and 2016. A medical subject heading search strategy was constructed for Medline searches by using a combination of relevant search terms, such as "microsimulation model medicine," "multistate modeling cancer," and "oncology." RESULTS: Microsimulation modeling is particularly useful for the study of optimal intervention strategies when randomized control trials may not be feasible, ethical, or practical. Microsimulation models can retain memory of prior behaviors and states. As such, it allows an explicit representation and understanding of how various processes propagate over time and affect the final outcomes for an individual or in a population. CONCLUSION: A well-calibrated microsimulation model can be used to predict the outcome of the event of interest for a new individual or subpopulations, assess the effectiveness and cost effectiveness of alternative interventions, and project the future disease burden of oncologic diseases. In the growing field of oncology research, a microsimulation model can serve as a valuable tool among the various facets of methodology available.
Authors: Andrew H Briggs; Milton C Weinstein; Elisabeth A L Fenwick; Jonathan Karnon; Mark J Sculpher; A David Paltiel Journal: Value Health Date: 2012 Sep-Oct Impact factor: 5.725
Authors: Reka Pataky; Roman Gulati; Ruth Etzioni; Peter Black; Kim N Chi; Andrew J Coldman; Tom Pickles; Scott Tyldesley; Stuart Peacock Journal: Int J Cancer Date: 2014-02-04 Impact factor: 7.396
Authors: Rafael Meza; Kevin ten Haaf; Chung Yin Kong; Ayca Erdogan; William C Black; Martin C Tammemagi; Sung Eun Choi; Jihyoun Jeon; Summer S Han; Vidit Munshi; Joost van Rosmalen; Paul Pinsky; Pamela M McMahon; Harry J de Koning; Eric J Feuer; William D Hazelton; Sylvia K Plevritis Journal: Cancer Date: 2014-02-27 Impact factor: 6.860
Authors: Jeanne S Mandelblatt; Kathleen A Cronin; Stephanie Bailey; Donald A Berry; Harry J de Koning; Gerrit Draisma; Hui Huang; Sandra J Lee; Mark Munsell; Sylvia K Plevritis; Peter Ravdin; Clyde B Schechter; Bronislava Sigal; Michael A Stoto; Natasha K Stout; Nicolien T van Ravesteyn; John Venier; Marvin Zelen; Eric J Feuer Journal: Ann Intern Med Date: 2009-11-17 Impact factor: 25.391
Authors: Thomas F Imperiale; Elizabeth A Glowinski; Ching Lin-Cooper; Gregory N Larkin; James D Rogge; David F Ransohoff Journal: N Engl J Med Date: 2008-09-18 Impact factor: 91.245
Authors: Annemieke Leunis; W Ken Redekop; Kees A G M van Montfort; Bob Löwenberg; Carin A Uyl-de Groot Journal: Pharmacoeconomics Date: 2013-07 Impact factor: 4.981
Authors: Deirdre A Hennessy; William M Flanagan; Peter Tanuseputro; Carol Bennett; Meltem Tuna; Jacek Kopec; Michael C Wolfson; Douglas G Manuel Journal: Popul Health Metr Date: 2015-09-03
Authors: Melinda M Davis; Siddhartha Nambiar; Maria E Mayorga; Eliana Sullivan; Karen Hicklin; Meghan C O'Leary; Kristen Dillon; Kristen Hassmiller Lich; Yifan Gu; Bonnie K Lind; Stephanie B Wheeler Journal: Prev Med Date: 2019-10-18 Impact factor: 4.018
Authors: Ross F Harrison; Scott B Cantor; Charlotte C Sun; Mariana Villanueva; Shannon N Westin; Nicole D Fleming; Iakovos Toumazis; Anil K Sood; Karen H Lu; Larissa A Meyer Journal: Gynecol Oncol Date: 2021-01-31 Impact factor: 5.482
Authors: Yibing Ruan; Abbey E Poirier; Joy Pader; Keiko Asakawa; Chaohui Lu; Saima Memon; Anthony B Miller; Stephen D Walter; Paul J Villeneuve; Will D King; Karena D Volesky; Leah Smith; Prithwish De; Christine M Friedenreich; Darren R Brenner Journal: Can J Public Health Date: 2021-05-25
Authors: Andrea Gini; Nicolien T van Ravesteyn; Erik E L Jansen; Eveline A M Heijnsdijk; Carlo Senore; Ahti Anttila; Dominika Novak Mlakar; Piret Veerus; Marcell Csanádi; Nadine Zielonke; Sirpa Heinävaara; György Széles; Nereo Segnan; Harry J de Koning; Iris Lansdorp-Vogelaar Journal: Prev Med Rep Date: 2021-04-30
Authors: Meghan C O'Leary; Kristen Hassmiller Lich; Leah Frerichs; Jennifer Leeman; Daniel S Reuland; Stephanie B Wheeler Journal: Implement Sci Date: 2022-04-15 Impact factor: 7.960